Results 231 to 240 of about 13,339,631 (403)

Landscape of BRAF transcript variants in human cancer

open access: yesMolecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda   +5 more
wiley   +1 more source

Assessing inflammatory protein biomarkers in COPD subjects with and without alpha-1 antitrypsin deficiency. [PDF]

open access: yesRespir Res
Moll M   +8 more
europepmc   +1 more source

Correction: Brucella modulates secretory trafficking via multiple Type IV secretion effector proteins. [PDF]

open access: yesPLoS Pathog
Myeni S   +7 more
europepmc   +1 more source

DETERMINATION OF PROTEIN IN URINE BY THE BIURET METHOD

open access: hybrid, 1948
Alma Hiller   +2 more
openalex   +1 more source

Bacillus thuringiensis and Its Pesticidal Crystal Proteins

open access: yesMicrobiology and Molecular Biology Reviews, 1998
E. Schnepf   +7 more
semanticscholar   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren   +16 more
wiley   +1 more source

Multiomics profiling reveals the involvement of protein lactylation in nonhomologous end joining pathway conferring radioresistance in lung adenocarcinoma cell. [PDF]

open access: yesSci Rep
He J   +14 more
europepmc   +1 more source

STUDIES ON HUMAN SERUM PROTEINS

open access: hybrid, 1941
Forrest E. Kendall
openalex   +1 more source

Home - About - Disclaimer - Privacy